Pancreatic Cancer Research

ResearcherZhengzhou UniversityActive in the last 2 years

Wenzhi Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0821-1318; OpenAlex author ID A5021275847. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2021: 5 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 9

  1. Development and validation of a nomogram for a prognostic model for resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hbpd.2025.04.005↗
  2. Dysfunctional epigenetic protein-coding gene-related signature is associated with the prognosis of pancreatic cancer based on histone modification and transcri… Last author DOI 10.1038/s41598-022-27316-2↗
  3. High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41598-022-22355-1↗
  4. Single-cell sequencing and establishment of an 8-gene prognostic model for pancreatic cancer patients. Last author DOI 10.3389/fonc.2022.1000447↗
  5. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma. Last author DOI 10.1038/s41598-021-96470-w↗
  6. Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer. Last author DOI 10.1042/bsr20210337↗
  7. Prognostic and clinicopathological significance of systemic immune-inflammation index in pancreatic cancer: a meta-analysis of 2,365 patients. Last author DOI 10.18632/aging.203449↗
  8. Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer. Last author DOI 10.3389/fcell.2021.698296↗
  9. A Prognostic Model of Pancreatic Cancer Based on Ferroptosis-Related Genes to Determine Its Immune Landscape and Underlying Mechanisms. Last author DOI 10.3389/fcell.2021.746696↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingyuan Zheng · 4 shared papers, 2021 · strength 0.62
  2. Shuijun Zhang · 3 shared papers, 2021–2022 · strength 0.51
  3. Xiao Yu · 3 shared papers, 2021 · strength 0.47
  4. Qiyao Zhang · 3 shared papers, 2021 · strength 0.47
  5. Xiao Yu · 2 shared papers, 2022–2023 · strength 0.41
  6. Tianliang Song · 1 shared paper, 2025 · strength 0.24
  7. Hao Hui Chen · 1 shared paper, 2025 · strength 0.24
  8. Yumin Li · 1 shared paper, 2025 · strength 0.24
  9. Huijuan Cheng · 1 shared paper, 2025 · strength 0.24
  10. Yun Wang · 1 shared paper, 2023 · strength 0.20
  11. Yun Wang · 1 shared paper, 2022 · strength 0.16
  12. Qi Liu · 1 shared paper, 2022 · strength 0.16
  13. Yong Wang · 1 shared paper, 2022 · strength 0.16
  14. Yifang Shui · 1 shared paper, 2021 · strength 0.16
  15. Xiao Yu · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.